Ignite Creation Date:
2024-05-05 @ 4:37 PM
Last Modification Date:
2024-10-26 @ 9:22 AM
Study NCT ID:
NCT00281294
Status:
TERMINATED
Last Update Posted:
2008-08-05
First Post:
2006-01-20
Brief Title:
A Phase 2 Study to Evaluate the Safety Tolerability and Activity of Fontolizumab in Subjects With Active Rheumatoid Arthritis
Sponsor:
PDL BioPharma Inc
Organization:
Facet Biotech
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Arthritis Rheumatoid |
Keywords:
| Name | View |
|---|---|
| Arthritis Rheumatoid | View |